M.R. Sydes
MRC Clinical Trials Unit at UCL(GB)University College London(GB)
Publications by Year
Research Areas
Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer(2021)183 cited
- Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: The MRC PRO6 trial(2004)
- → 1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials(2024)9 cited
- → 939 Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection to transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder(2015)1 cited
- UKLG LY09: A randomised controlled trial of ABVD vs two multi-drug regimens for advanced Hodgkin's lymphoma - initial results(2004)